EMuNI Project: Multiple Nonpharmacological Interventions

Sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli (Other)
Overall Status
Completed
CT.gov ID
NCT03382353
Collaborator
Ospedale San Raffaele (Other), Istituto Di Ricerche Farmacologiche Mario Negri (Other)
120
2
3
29
60
2.1

Study Details

Study Description

Brief Summary

By 2030, the global prevalence of Alzheimer's Disease (AD) is predicted to reach 65.7 million worldwide. Despite extensive research efforts, a cure for AD has not been identified. Recent studies on non-demented individuals have demonstrated the importance of a healthy lifestyle (physical exercise, healthy diet) and non pharmacological interventions (diet supplements) to delay the onset of the cognitive decline (Vemuri P et al., 2012). Given that AD is a multi-factorial disorder, some multi- component interventions at early stages could be the best strategy currently available to delay the AD onset. The aim of this study is to investigate the effects of combined non-pharmacological interventions, at different levels of intensity, on cognitive performance, on basic (hippocampal, brain ventricle volumes and white matter lesions) and advanced magnetic resonance imaging (MRI) markers (Resting-state Functional MRI, Probabilistic Diffusion Tensor Tractography

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Nutritional supplementation
  • Behavioral: Educational training
  • Behavioral: Counselling on a brain-healthy diet
  • Behavioral: Physical exercise training
  • Behavioral: Computerized cognitive training
N/A

Detailed Description

BACKGROUND Recent evidence showed that aerobic exercise, dietary habits and nutritional supplements consumption seem essential for maintaining good cognitive performances increasing hippocampal volume (HV) in healthy elderly people (Erickson et al., 2011; Bowman et al., 2012). Computerized cognitive trainings are effective in improving cognitive functions of healthy older adults (Lampit et al., 2014). Subjective memory complaint (SMC) individuals showed HV, white matter lesions (WML) and brain ventricle volumes (BVV) at limits of normative population (Cavedo et al., 2012) supporting the hypothesis that they are persons at risk of AD (Sperling et al., 2011). The above non-pharmacological treatments, when separately applied, do not impact on cognition and neuropathological processes of AD. On the contrary, combined treatments, in persons at risk to develop AD, could represent the first line of intervention to delay the onset of cognitive impairment.

SPECIFIC AIMS

  1. To investigate the combined effect of aerobic exercise, dietary habits, nutritional supplements, and cognitive training administered at three different levels of intensity on cognitive performance in subjective memory complaints individuals. The three different intensity levels of nonpharmacological treatments will be organized as follows: (i) No Treatment (NT) will include educational training (sham condition); (ii) Partial Treatment (PT) will include exclusively the consumption of a nutritional supplement and a training for a balanced diet; (iii) Full treatment (FT) will include all above condition plus computerized cognitive training (no sham condition) and aerobic fitness training.

  2. To investigate the effect of the above treatments (NT, PT, FT) on basic markers of magnetic resonance imaging (MRI) such as HV, WML and Brain Ventricle Volume (BVV) in subjective memory complaints individuals.

  3. To investigate the effect of NT, PT and FT on advanced MRI markers such as structural brain connectivity and brain resting networks in subjective memory complaints individuals.

HYPHOTESIS AND SIGNIFICANCE An improvement in cognitive performances, basic (HV, WML, BVV) and advanced (structural brain connectivity and brain resting networks) MRI markers will be expected in FT group compared to NT group. Moreover, the investigators hypothesize an effect dependent of the number of combined treatments, thus the PT group is expected to show intermediate results (among NT and FT groups) in the cognitive performances, basic and advanced MRI markers previously described.

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Efficacy of Multiple Nonpharmacological Interventions in Individuals With Subjective Memory Complaints
Study Start Date :
Jan 1, 2016
Actual Primary Completion Date :
Jun 1, 2017
Actual Study Completion Date :
Jun 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: No Treatment (NT)

Educational training

Behavioral: Educational training
16 educational lessons (twice a week): basic principles of different cognitive domains (e.g. memory, attention, perception) and educational DVD viewing.

Experimental: Partial Treatment (PT)

Nutritional supplementation & Counselling on a brain-healthy diet

Dietary Supplement: Nutritional supplementation
Daily consumption of Tramiprosate (100 mg) for 1 year

Behavioral: Counselling on a brain-healthy diet
4 lessons on the principles of Mediterranean Diet lead by a nutritionist, aimed to teach how to include brain-healthy foods in daily diet (e.g. antioxidant, omega-3 fatty acids and vitamins). Each participant will receive the educational material presented.

Experimental: Full Treatment (FT)

Nutritional supplementation & Counselling on a brain-healthy diet & Physical exercise training & Computerized cognitive training

Dietary Supplement: Nutritional supplementation
Daily consumption of Tramiprosate (100 mg) for 1 year

Behavioral: Counselling on a brain-healthy diet
4 lessons on the principles of Mediterranean Diet lead by a nutritionist, aimed to teach how to include brain-healthy foods in daily diet (e.g. antioxidant, omega-3 fatty acids and vitamins). Each participant will receive the educational material presented.

Behavioral: Physical exercise training
80 sessions of physical exercise supervised by a Fitness Training Expert with the aim of achieving 150 minutes of moderate-intensity physical activity per week

Behavioral: Computerized cognitive training
16 cognitive training sessions (twice a week) supervised by a psychologist, aimed to improve Attention, Processing speed, Memory, Social skills and Intelligence using BrainHQ (www.brainhq.com).

Outcome Measures

Primary Outcome Measures

  1. Cognitive functions [12 months]

    Neuropsychological test performances

Secondary Outcome Measures

  1. Basic imaging marker 1 [12 months]

    Hippocampal volumes

  2. Basic imaging marker 2 [12 months]

    White matter hyperintensities volumes

  3. Basic imaging marker 3 [12 months]

    Brain ventricle volumes

Other Outcome Measures

  1. Advanced imaging marker 1 [12 months]

    Structural brain connectivity

  2. Advanced imaging marker 2 [12 months]

    Functional networks connectivity at rest

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • age between 60 and 80 years;

  • presence of memory complaints

Exclusion Criteria:
  • objective cognitive impairment on standard neuropsychological testing;

  • history of psychiatric disorders or current clinically relevant depressive or anxious symptoms;

  • pacemakers, cochlear implant, metal inserts in the head or shoulders

Contacts and Locations

Locations

Site City State Country Postal Code
1 IRCCS Centro San Giovanni di Dio Fatebenefratelli Brescia Italy 25125
2 Ospedale San Raffaele Milan Italy 20132

Sponsors and Collaborators

  • IRCCS Centro San Giovanni di Dio Fatebenefratelli
  • Ospedale San Raffaele
  • Istituto Di Ricerche Farmacologiche Mario Negri

Investigators

  • Principal Investigator: Enrica Cavedo, PhD, IRCCS Centro San Giovanni di Dio Fatebenefratelli

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Enrica Cavedo, Principal Investigator, IRCCS Centro San Giovanni di Dio Fatebenefratelli
ClinicalTrials.gov Identifier:
NCT03382353
Other Study ID Numbers:
  • GR-2011-02350494
First Posted:
Dec 22, 2017
Last Update Posted:
Sep 14, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Enrica Cavedo, Principal Investigator, IRCCS Centro San Giovanni di Dio Fatebenefratelli

Study Results

No Results Posted as of Sep 14, 2021